Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin A injection into the subscapular muscle for post-stroke shoulder pain
NL-OMON27111Active, not recruiting
- Sponsor
- Allergan
- Start
- Nov 2002
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial of botulinum toxin type A in hemiplegic shoulder pain (PHS) (2 arms), sponsored by Allergan. Primary endpoints: Pain score and Range of motion of glenohumeral joint. Started Nov 2002; status: active, not recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
hemiplegic shoulder pain (PHS)
Beyond the preview
Go deeper on NL-OMON27111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27111.